Month: March 2024

• investments

Popular Vehicles (IPO) is a dealer for Maruti Suzuki and Tata Motors. Subscribe the issue for long term investment horizon: SBI Securities

Arjun March 12, 2024

In FY23, the company is the 7th largest Maruti Suzuki dealer under Arena and...

Read More

• investments

J Kumar Infraprojects is an Important Player to Ride on Indian Urban Infrastructure Landscape. Buy for target price of Rs 900 (25% upside): Axis Securities

Arjun March 11, 2024

We initiate coverage on J Kumar Infraprojects Limited (JKIL) with a BUY recommendation and...

Read More

• investments

CAN FIN Homes is poised for stronger performance. Buy for target price of Rs 1000 (25.8% upside): YES Securities

Arjun March 10, 2024

In the Investor Meetings hosted by us, Can Fin Homes have expressed significant ...

Read More

• investments

HDFC Bank’s merger related negatives are in price; valuation re-rating is expected. Buy for target price of Rs 1762 (22% upside): LKP

Arjun March 9, 2024

HDFC Bank is expected to overcome the merger overhangs gradually led by 1) healthy...

Read More

• investments

Nippon Life India Asset Management is at 32% discount to HDFC AMC. Buy for target price of Rs 610: PL

Arjun March 9, 2024

We initiate coverage on NAM with ‘BUY’ rating given (1) consistent equity outperformance...

Read More

• investments

Top Specialty Chemical Stocks to buy for up to 40.3% upside potential by Deven Choksey Research

Arjun March 8, 2024

We recommend Rossari Biotech as the Company has strong demand from end customer segments,...

Read More

• investments

Gopal Snacks Limited (IPO) is the largest manufacturer of Gathiya (31% market share) and has ~20 market share in total ethnic savouries market. Subscribe: SBI Sec

Arjun March 8, 2024

Gopal Snacks Ltd is a fast-moving consumer goods company based in India, offering a...

Read More

• investments

Top Stock Picks based on 3QFY24 Results by SBI Securities for Investment Horizon of 12 Months

Arjun March 7, 2024

We started this product on 16th June 2022 to offer our investors (A) An...

Read More

• investments

Top 4 Pharma Stocks to buy now by HDFC Securities

Arjun March 6, 2024

Domestic formulations sector: secular growth stories The India Pharma Market (IPM) has maintained a...

Read More

• investments

Union Bank of India’s continued healthy growth and steady RoA will drive valuation. Buy for target price of Rs 180 (22% upside): ICICI Direct

Arjun March 5, 2024

At CMP, the stock is trading 0.9x FY26E ABV which seems reasonable with steady...

Read More